Welcome

welcomeThe King's Thrombosis Centre is a leading multidisciplinary clinical and research group dedicated to the diagnosis and treatment of hypercoagulable conditions. We are a designated Haemophilia Centre and were the first National Venous Thromboembolism (VTE) Exemplar Centre, reflecting our national leadership in the prevention and treatment of VTE. Our clinical trials unit works in partnership with industry to develop new treatments for VTE prevention and treatment.

 

 

The FIRST Registry

With the next generation of oral anticoagulants entering clinical practice, the FIRST registry will provide an important data tool to increase knowledge and improve the quality of care of patients with VTE. Read more...

Exemplar Centre Network website

Web

The Exemplar Centre Network website has moved. After being hosted at the King's Thrombosis Centre website since its launch in 2007, the website will now be managed as part of the National VTE prevention Programme and can be accessed by clicking here.

Latest News

  • Anticoagulation news items. Week commencing 23rd March 2015
    Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised…
  • Anticoagulation news items. Week commencing 16th March 2015
      Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised The Lancet This meta-analysis concluded that shorter…
  • Anticoagulation news items. Week commencing 9th March 2015
    Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines British Medical Journal This research finds guideline recommendations often don't consider potential drug-drug or -disease interactions…